Overexpression of RBM24 prevents tumor cell growth and induces sorafenib sensitivity by indirectly reducing the expression level of p63 mRNA likely through inhibition of β-catenin nuclear translocation [30]. This evidence concerns the gene RBM24 and neoplasm.